GlassScriptPhysician profile
Carly B Shaw
NPI 1689229809
$1,468.52
in general payments reported to CMS, 2019-2025
14 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $235 · 2022: $144 · 2023: $420 · 2024: $421 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $424.46 | 2021-2025 | Dupixent |
| Abbvie INC. | $175.73 | 2021-2025 | |
| Genzyme Corporation | $171.34 | 2021-2024 | |
| Pfizer INC. | $168.19 | 2024-2025 | |
| Stryker Corporation | $100.45 | 2023-2024 | Scopis Ent, Xpress Ent Dilation System |
| Lucid Diagnostics INC. | $86.75 | 2024 | |
| Glaxosmithkline, LLC. | $85.63 | 2021-2025 | Nucala |
| Optinose US, INC. | $65.02 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $60.63 | 2023-2025 | Keytruda |
| Kaleo, INC. | $35.78 | 2023 | Auvi-Q |
| Hologic Sales and Service, LLC | $32.66 | 2025 | Coolseal Generator |
| Novartis Pharmaceuticals Corporation | $26.63 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $19.99 | 2025 | Tezspire |
| Medtronic, INC. | $15.26 | 2025 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.